Haemonetics (HAE) Depreciation and Depletion (2018 - 2026)

Haemonetics has reported Depreciation and Depletion for 6 years, with the latest figure at $15.3 million in Q1 2026.

• For the quarter ending Q1 2026, Depreciation and Depletion rose 0.66% year-over-year to $15.3 million; the trailing twelve-month figure through Mar 2026 stood at $61.1 million (up 1.83% YoY), and the FY2026 full-year result was $61.2 million, up 2.0% from the prior year.
• Depreciation and Depletion for Q1 2026 stood at $15.3 million, up from $14.9 million in the prior quarter.
• The five-year high for Depreciation and Depletion was $15.5 million in Q3 2025, with the low at $11.7 million in Q3 2022.
• Average Depreciation and Depletion over 5 years is $14.3 million, with a median of $14.6 million recorded in 2024.
• Year-over-year, Depreciation and Depletion increased 13.68% in 2023 and slipped 1.97% in 2025.
• Tracing HAE's Depreciation and Depletion over 5 years: stood at $13.1 million in 2022, then grew by 8.4% to $14.2 million in 2023, then increased by 7.04% to $15.2 million in 2024, then dropped by 1.97% to $14.9 million in 2025, then increased by 2.68% to $15.3 million in 2026.
• The last three Depreciation and Depletion figures came in at $15.3 million (Q1 2026), $14.9 million (Q4 2025), and $15.5 million (Q3 2025), per Business Quant data.

Peer Comparison